Diversity of regulatory CD4+Tcells controlling distinct organ-specific autoimmune diseases

Authors:

Abstract
Depletion of selected regulatory CD4+T cell subsets induces the spontaneous onset of various immune or autoimmune disorders. It is not clear, however, whether a given subset, notably CD4+CD25+regulatory T cells, protects from a wide spectrum of immune disorders, or whether specialized subsets of regulatory T cells control each given disease or group of diseases. We report here, using diabetes prone nonobese diabetic (NOD) mice, that depending on the regulatory T cells that are depleted, i.e., CD25+, CD62L+, or CD45RBlow, distinct immune diseases appear after transfer into NOD severe combined immunodeficiency (SCID) recipients. Thus, reconstitution of NOD SCID mice with CD25-T cells induces major gastritis and late-onset diabetes, but no or mild colitis. Reconstitution with CD62L-T cells induces fulminant diabetes with no colitis or gastritis. Reconstitution with CD45RBhighT cells induces major colitis with wasting disease and no or very moderate gastritis and diabetes. Major differences among the three regulatory T cell subsets are also seenin vitro. The bulk of suppressor cells inhibiting the proliferation of CD4+CD25-T cells in coculture is concentrated within the CD25+but not the CD62L+or CD45RBlowT cell subsets. Similarly, cytokine production patterns are significantly different for each regulatory T cell subset. Collectively, these data point to the diversity and organ selectivity of regulatory T cells controlling distinct autoimmune diseases whatever the underlying mechanisms.

This publication has 28 references indexed in Scilit: